SuperworthEnsysce Biosciences shares outstanding ENSC
Diluted shares outstanding, averaged over each quarter, from 2018.
- Latest quarter, to Jun 30, 2026
- 13M
- On a year earlier
- +491.9%
- more shares
Ensysce Biosciences had 13M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 491.9% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 3.7M | +202% |
| FY2024 | 1.2M | +606% |
| FY2023 | 174.4K | +767% |
| FY2022 | 20.1K | +198% |
| FY2021 | 6.8K | +47% |
| FY2020 | 4.6K | +169% |
| FY2019 | 1.7K | +2% |
| FY2018 | 1.7K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 13M | +492% | |
| Q1 FY26 | 6.8M | +388% | |
| Q4 FY25 | 3.7M | +202% | |
| Q3 FY25 | 2.9M | +338% | |
| Q2 FY25 | 2.2M | +275% | |
| Q1 FY25 | 1.4M | +269% | |
| Q4 FY24 | 1.2M | +606% | |
| Q3 FY24 | 659.4K | +221% | |
| Q2 FY24 | 587.8K | +288% | |
| Q1 FY24 | 379.6K | +440% | |
| Q4 FY23 | 174.4K | +767% | |
| Q3 FY23 | 205.7K | +1820% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Ensysce Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.